Search results
Results from the WOW.Com Content Network
In 2010, with her research team of the Sloan-Kettering Cancer Center, she demonstrated the fact that tumorous blood vessel cells may come from tumor cells as a way to create their own blood supply. Those results contributed to demonstrate the great plasticity of tumors. [8] A prolific author, she has written dozens of widely cited publications.
Lewis was a Professor of Surgery and Medicine Memorial Sloan-Kettering Cancer Center, [3] before working in the biotechnology and healthcare industries, serving in several CEO and Chairman roles. He is currently chairman and co-founder of the Molecular Ninja Group and chairman and co-founder of Dugri Inc .
Malcolm A. S. Moore (born January 18, 1944) is a British American biologist who is the Enid A. Haupt Chair of Cell Biology at the Memorial Sloan-Kettering Cancer Center. Moore is an oncologist and hematologist known for being the principal investigator in the development of filgrastim. He is a member of various national and international ...
[1] [6] While there, he joined a Stand Up to Cancer “Dream Team” against pancreatic cancer as a co-Principal Investigator alongside Craig B. Thompson. [ 7 ] [ 8 ] [ 9 ] In 2017, Drebin moved to Memorial Sloan Kettering to become Department of Surgery Chair. [ 1 ]
Thomas J. Kelly is an American cancer researcher whose work focuses on the molecular mechanisms of DNA replication. Kelly is director of the Sloan-Kettering Institute, [4] [5] the basic research arm of the Memorial Sloan-Kettering Cancer Center. He holds the Center's Benno C. Schmidt Chair of Cancer Research.
In 2017, Diaz became Head of the Solid Tumor Oncology division at Memorial Sloan Kettering. The same year, he was selected to lead the Stand Up to Cancer “Dream Team” against colorectal cancer. [5] Diaz has founded several companies that focus on genomic analyses of cancers, including Inostics, [6] PapGene, [7] and Personal Genome ...
Dana Pe'er (born 1971), Chair and Professor in Computational and Systems Biology Program at Sloan Kettering Institute is a researcher in computational systems biology. A Howard Hughes Medical Institute (HHMI) Investigator since 2021, she was previously a professor at Columbia Department of Biological Sciences.
Robert E. Wittes was Physician-in-Chief of Memorial Sloan-Kettering Cancer Center, from 2002 until December 31, 2012.Prior to his appointment at MSKCC, he was Deputy Director for Extramural Sciences and Director of the Division of Cancer Treatment and Diagnosis at the National Cancer Institute, where he oversaw NCI's extramural clinical and basic research programs, including the evaluation of ...